Mahesh Balakrishnan, Angelini Gianni, Caputo Massimo, Jin Xu Yu, Bryan Alan
Cardiothoracic Center, Bristol Royal Infirmary, Bristol, United Kingdom.
Ann Thorac Surg. 2005 Sep;80(3):1151-8. doi: 10.1016/j.athoracsur.2004.11.001.
Prosthetic valve endocarditis is a catastrophic complication of cardiac valve replacement, associated with high mortality rates. Medical treatment is effective in a few instances of endocarditis involving the leaflets alone in bioprostheses. However, accurate diagnosis, better myocardial protection, and improved surgical strategies have led to better survival in patients undergoing surgery after failed conservative therapy. This comprehensive review addresses various issues involved in the management of this complication.
人工瓣膜心内膜炎是心脏瓣膜置换术后的一种灾难性并发症,死亡率很高。对于生物瓣膜仅累及瓣叶的心内膜炎,药物治疗在少数情况下有效。然而,准确的诊断、更好的心肌保护以及改进的手术策略使保守治疗失败后接受手术的患者生存率提高。这篇综述探讨了该并发症管理中涉及的各种问题。